Main Purpose of the Job
The role of the Commercialisation Manager is to support the Head of BDI in delivering Knowledge Exchange, Commercialisation, and Impact Strategies. The successful applicant will bring their own experience, expertise and professional networks to help Earlham to deliver knowledge exchange activities and generate impact.
Medicilon's preclinical pharmacology and toxicology research team is equipped with a professional send format conversion team and has established a send data conversion platform that is fully developed in terms of software, technology, specification and quality, to realize accurate data conversion and provide a good environment for electronic data submission. In recent years, Medicilon SEND team helped customers complete many send data conversion projects within very tight timeline and filed timely with FDA.
Patents directed to medical devices can be of great commercial value. However, claims relating to medical devices can fall foul of the European patent office’s statutory exclusions of medical methods, so care needs to be taken both during drafting and prosecution at the EPO. This webinar will discuss some of the issues faced in applications relating to medical devices at the EPO, and provide guidance on how to optimise claim coverage.
Topics will include:
• An overview of EPO exclusions from patentability relevant to medical devices
Applications are invited for a Flow Cytometry and Histology Research Support Scientist to join the Core Facility Services Team at the Quadram Institute Bioscience (QIB), based in Norwich, UK.
The role:
Join the Pharmaron team on December 5th at 8am PT / 11am ET / 4pm GMT for an in-depth exploration of macrocycles in drug design and discovery!
In this webinar, Mike Waring, Professor and Head of Medicinal Chemistry at Newcastle University, and Sébastien Campos, Senior Director of Medicinal Chemistry at Pharmaron, will explore how macrocycles are transforming the field. Discover key principles for rational macrocycle design and learn about the unique benefits and challenges of this compound class.
Cambridge, UK – November 15, 2024 – Stilla Technologies, a global leader in digital PCR (dPCR) solutions, has announced a strategic partnership with Source BioScience, a leading UK-based genomics service provider. This collaboration will bring cutting-edge dPCR technology to the forefront of molecular genetics in the UK and Ireland, with Source BioScience becoming the first provider in the region to offer Stilla’s NIO system.
A fantastic result for the Cushman & Wakefield EMEA Research and Insight team, taking the top spots at The Ian Cullen Research Prize at the Society of Property Researchers Annual Dinner.
The prize is for presentation of new data, innovative analysis and new ways of thinking.
The shortlist for the Open prize whittled down to just two papers – both by Cushman & Wakefield – Kiran Patel’s Locating Science and Sally Bruer’s European City Logistics.
The final selection for best research paper was awarded to Kiran Patel for Locating Science.
Details: Full-time; permanent contract; based at Alderley Park, Cheshire (due to laboratory role, this is an on-site based position)
About us
Based at Alderley Park, Infex Therapeutics is a clinical-stage R&D infectious disease company that develops innovative drugs to treat infections with high unmet medical need and pandemic potential.
More details at: https://www.infextx.com/
Details: Full-time; permanent contract; based at Alderley Park, Cheshire (due to laboratory role, this is an on-site based position).
About us
Based at Alderley Park, Infex Therapeutics is a clinical-stage R&D infectious disease company that develops innovative drugs to treat infections with high unmet medical need and pandemic potential.
More details at: https://www.infextx.com/